AGENUS INC (AGEN) - ์ข ํฉ์ ์ธ ์ฃผ์ ๋ถ์ ๋ฐ ํฌ์ ๋ฆฌ์์น
Deep dive into AGENUS INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Understanding Company Overview
What this section covers: Essential business information about AGENUS INC, including sector classification, industry positioning, and organizational structure.
How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.
AGENUS INC์ ๊ฒฝ์ฐ: AGENUS INC operates in the Life Sciences sector, making it an emerging small-cap investment.
AGENUS INC (์ฃผ์ ๊ธฐํธ: AGEN) ๋ Life Sciences ๋ถ๋ฌธ์ ์ ๋ ๊ธฐ์ ์ ๋๋ค. ํนํ Biological Products, (No Diagnostic Substances) ์ฐ์ ๋ด์์ ์ด์๋ฉ๋๋ค..
์ ์ธ๊ณ ์ฝ 307๋ช ์ ์ ๋ฌธ๊ฐ๋ฅผ ๊ณ ์ฉํ๊ณ ์์ต๋๋ค. .
ํ์ฌ ๋ก ์๋ฆฌ๋งค๊นํ์ต๋๋ค. ์๋นํ ์ฑ์ฅ ์ ์ฌ๋ ฅ์ ๊ฐ์ง ์๋ก์ด ํฌ์ ๊ธฐํ.
Understanding Financial Performance
์ด๋ฌํ ๋ฉํธ๋ฆญ์ ์๋ฏธ: Key financial indicators showing AGENUS INC's revenue scale, profitability, market value, and shareholder returns.
์ฝ๋ ๋ฐฉ๋ฒ: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
AGENUS INC์ ๊ฒฝ์ฐ: With $101M in annual revenue and -2061.7% net margin, the company demonstrates developing profitability.
์ฐ๊ฐ ์์ต: $101 ๋ฐฑ๋ง -2061.7% ์์ด์ต๋ฅ ์์ฑ .
์๊ฐ์ด์ก: $130 ๋ฐฑ๋ง - ๋ก ๋ถ๋ฅ ๋์ ์ฑ์ฅ ์ ์ฌ๋ ฅ์ ์ ๊ณตํ๋ ์ํ์ฃผ ํฌ์.
์๊ธฐ์๋ณธ ์์ต๋ฅ (ROE): -805.0% - ํ๊ท ์ดํ ์ฃผ์ฃผ ํ์ ํจ์จ์ฑ์ ๋ํ๋ด๋ ์ด์ ๊ฐ์ ์ด ํ์ํ ์์ญ.
Understanding AI Stock Predictions
What these predictions mean: AI-powered forecasts for AGENUS INC stock using machine learning algorithms trained on historical market data and technical indicators.
How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.
AGENUS INC์ ๊ฒฝ์ฐ: Unlock premium access to view detailed AI predictions and price targets.
๐ ํ๋ฆฌ๋ฏธ์ AI ์์ธก ๊ธฐ๋ฅ ์ ๊ธ ํด์ ๋ฅผ ํด๋ฆญํ๋ฉด 7์ผ, 30์ผ, 90์ผ ๊ฐ๊ฒฉ ๋ชฉํ์ ์ ๋ขฐ ๊ตฌ๊ฐ ๋ฐ ์ํ ํ๊ฐ๋ฅผ ํฌํจํ AGENUS INC ์ฃผ์์ ๋ํ ๊ณ ๊ธ ๋จธ์ ๋ฌ๋ ์์ธก์ ์ก์ธ์คํ ์ ์์ต๋๋ค.
Understanding Market Position
What this analysis covers: AGENUS INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.
How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.
AGENUS INC์ ๊ฒฝ์ฐ: Market positioning analysis based on available financial and operational metrics.
AGENUS INC๋ ๋งค์ฐ ์ญ๋์ ์ธ ํ๊ฒฝ์์ ์ ๋ต์ ์ผ๋ก ๊ฒฝ์ํฉ๋๋ค. Biological Products, (No Diagnostic Substances) ๋ง์ผํ๋ ์ด์ค, ์๋นํ ์ฑ์ฅ ์ ์ฌ๋ ฅ๊ณผ ์์ฅ ํ๊ดด์ ์ญ๋์ ๊ฐ์ถ ์ ํฅ ์ํ์ฃผ ํฌ์๋ฅผ ๋ํํฉ๋๋ค. .
์ด ํ์ฌ๋ ๊ฑด์ ํ 39.6% ์ด ๋ง์ง์ ์ ์งํ์ฌ ๊ฐ๋ ฅํ ๊ฐ๊ฒฉ ์ฑ ์ ๋ ฅ๊ณผ ์ด์ ํจ์จ์ฑ์ ๋ํ๋ ๋๋ค.